Back
Monopar Therapeutics, Inc. Stock Predictions
BlackRock's $91B Secret
Learn how to access Native Markets before Coinbase. Watch the free training.
Sell
38
MNPR
Monopar Therapeutics, Inc.
Last Price:
$66.01
Seasonality Move:
9.84%
7 Day Trial
ALL ACCESS PASS
$
7
Where Smart Money Buys Crypto (Hint: Not Coinbase)
Access Native Markets before the next 100x asset goes mainstream. Watch free training.Monopar Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Monopar Therapeutics, Inc. has on average historically risen by 194.6% based on the past 6 years of stock performance.
-
Monopar Therapeutics, Inc. has risen higher in 2 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%
-
Is Monopar Therapeutics, Inc. Stock Undervalued?The current Monopar Therapeutics, Inc. [MNPR] share price is $65.30. The Score for MNPR is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
-
MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Monopar Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Monopar Therapeutics, Inc. has on average historically risen by 194.6% based on the past 6 years of stock performance.
Monopar Therapeutics, Inc. Stock Rating
Sell
38
Monopar Therapeutics, Inc. (MNPR)
is a Sell
Is Monopar Therapeutics, Inc. overpriced?
-
Monopar Therapeutics, Inc. has risen higher in 2 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%
Monopar Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
monopartx.com
52-Week Data
52-Week High:
105.00
52-Week Low:
21.00
Prediction Charts
Market Cap:
441.1M
Price in USD:
65.30
Volume:
285.5K
Beta:
1.42
Technical Analysis
SMA50:
78.70
SMA100:
69.37
SMA200:
53.66
52-Wk Change:
197.07%
Stock Predictions
-
Is Monopar Therapeutics, Inc. stock public?Yes, Monopar Therapeutics, Inc. is a publicly traded company.
-
What is the Monopar Therapeutics, Inc. stock quote today?The Monopar Therapeutics, Inc. stock price is 65.30 USD today.
-
How to buy Monopar Therapeutics, Inc. stock online?You can buy Monopar Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-11 | 78.72 | 77.05 | 79.02 | 75.00 |
| Dec-12 | 76.51 | 74.61 | 76.90 | 73.63 |
| Dec-15 | 74.88 | 75.12 | 77.45 | 74.18 |
| Dec-16 | 74.17 | 71.47 | 75.21 | 68.89 |
| Dec-17 | 71.69 | 67.70 | 73.00 | 66.93 |
| Dec-18 | 68.87 | 65.99 | 68.90 | 64.25 |
| Dec-19 | 65.77 | 68.63 | 70.11 | 65.77 |
| Dec-22 | 68.55 | 70.92 | 73.25 | 68.37 |
| Dec-23 | 70.84 | 70.50 | 74.34 | 70.15 |
| Dec-24 | 69.80 | 70.78 | 72.47 | 69.39 |
| Dec-26 | 70.78 | 68.77 | 72.24 | 67.62 |
| Dec-29 | 67.81 | 65.57 | 70.42 | 65.53 |
| Dec-30 | 66.20 | 65.07 | 69.03 | 64.79 |
| Dec-31 | 64.49 | 65.30 | 65.60 | 63.73 |
Monopar Therapeutics, Inc. Earnings
Monopar Therapeutics, Inc. Earnings Report: Per Share Monopar Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Monopar Therapeutics, Inc. Forecast Revenue Growth
Monopar Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Monopar Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.78 per share, and a decrease next year of $0.34 per share.
* Monopar Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.